Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

363738394041424344

Illumina collaborates with AstraZeneca on AI-focused research

12th Oct 2022 07:23

(Alliance News) - Illumina Inc on Tuesday said it is collaborating with AstraZeneca PLC on drug target discovery, with a focus on artificial intelligence-based research on genes. Read More

LONDON BROKER RATINGS: GSK raised to 'outperform'; RBC cuts THG

29th Sep 2022 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday: Read More

TOP NEWS: AstraZeneca's Tezspire and Koselugo approved in Japan

27th Sep 2022 09:25

(Alliance News) - AstraZeneca PLC on Tuesday said its Tezspire and Koselugo drugs have been approved in Japan for the treatment of severe asthma and patients that suffer from a rare genetic condition, respectively. Read More

TOP NEWS: GSK names Burberry's Julie Brown as new CFO from May

26th Sep 2022 08:55

(Alliance News) - GSK PLC on Monday announced a change in leadership, after its Chief Financial Officer Iain Mackay decided to retire. Read More

TOP NEWS: AstraZeneca's Ultomiris approved in EU for myasthenia gravis

23rd Sep 2022 08:19

(Alliance News) - AstraZeneca PLC on Friday said its Ultomiris drug has been approved in the EU to treat myasthenia gravis, a condition which causes muscle weakness. Read More

LONDON BRIEFING: Smiths annual revenue rises; Made.com up for sale

23rd Sep 2022 07:43

(Alliance News) - European markets are set to end a difficult week in decent fashion on Friday, as investors take onboard a series of hawkish central bank moves. Read More

TOP NEWS: AstraZeneca's Lynparza approved in China for ovarian cancer

22nd Sep 2022 08:41

(Alliance News) - AstraZeneca PLC on Thursday, along with pharmaceutical peer Merck & Co Inc, said that Lynparza has been approved in China for the maintenance treatment of adults with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. Read More

LONDON BRIEFING: Lower call; JD Sports suffers interim profit fall

22nd Sep 2022 07:46

(Alliance News) - Stocks in London are set to open lower on Thursday, ahead of a major interest rate decision by the Bank of England and a day after the US Federal Reserve settled for another three-quarter-point rate hike. Read More

WPP grows in Latin America with JeffreyGroup acquisition

21st Sep 2022 15:31

(Alliance News) - Advertising company WPP PLC said it has boosted its Latin American presence with a deal to acquire JeffreyGroup. Read More

TOP NEWS: AstraZeneca's Tezpire approved in EU for severe asthma

21st Sep 2022 08:54

(Alliance News) - AstraZeneca PLC on Wednesday its Tezpire severe asthma treatment has been approved in the EU by the European Commission. Read More

LONDON BRIEFING: Flat call; Aveva gets offer from Schneider Electric

21st Sep 2022 07:59

(Alliance News) - Stocks in London are set to open unchanged on Wednesday ahead the US Federal Reserve's interest rate decision later in the day and the Bank of England's decision on Thursday. Read More

TOP NEWS: AstraZeneca's Evusheld approved in EU for Covid-19 treatment

20th Sep 2022 08:58

(Alliance News) - AstraZeneca PLC on Tuesday said its Evusheld treatment for Covid-19 has been approved for use in the EU. Read More

LONDON BRIEFING: Haleon reports double-digit revenue growth

20th Sep 2022 07:51

(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II. Read More

LONDON MARKET OPEN: Recession and inflation fears dominate attention

16th Sep 2022 08:43

(Alliance News) - The mood remained downbeat at the end of a sour week for global equities, after data dashed hopes that US inflation is easing fast enough to warrant less aggressive interest rate hikes by the Federal Reserve. Read More

TOP NEWS: Two AstraZeneca drugs get recommendations for EU approval

16th Sep 2022 08:16

(Alliance News) - AstraZeneca PLC on Friday said it received two recommendations for drug approvals in the EU, while a drug for blood disorder paroxysmal nocturnal haemoglobinuria met its primary endpoint in a phase three trial. Read More

LONDON BRIEFING: UK retail sales fall much steeper than expected

16th Sep 2022 07:49

(Alliance News) - Stocks in London are set to end a difficult week on a downbeat note after economic data raised the prospect of the Federal Reserve acting even more aggressively to tame inflation. Read More

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

15th Sep 2022 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday: Read More

CORRECT: AstraZeneca shares further information on oncology trial data

14th Sep 2022 14:43

(Clarifying details of Poseidon trial.) Read More

AstraZeneca shares further Imfinzi, Tagrisso, Enhertu trial data

12th Sep 2022 08:44

(Alliance News) - AstraZenea PLC on Monday shared several positive developments for its oncology pipeline, which will be presented at the European Society for Medical Oncology Congress 2022 in Paris. Read More

AstraZeneca, Merck's Lynparza shows survival benefit in ovarian cancer

9th Sep 2022 14:31

(Alliance News) - AstraZeneca PLC and Merck & Co Inc on Friday said their cancer drug lynparza, or olaparib, showed positive overall survival data for patients with ovarian cancer in three phase III studies. Read More

363738394041424344
FTSE 100 Latest
Value10,126.78
Change-68.57